CurrentHealth-New-EnglandPolicy N/A

2026 Pharmacy Benefit Options for HMO Essential 5000 LG

Defines Health New England's 2026 pharmacy benefit tier structures (3-tier and 5-tier) and associated member copay amounts and rules for HMO Essential 5000 LG plans; affects members in the plan(s) described and their prescribing providers and pharmacies.

Policy Summary

PayerHealth-New-England

Policy2026 Pharmacy Benefit Options for HMO Essential 5000 LG

Policy CodePolicy N/A

Change TypeNo material change

Effective DateJan 1, 2026

Next Review DateN/A

Key ActionProviders may request prior authorization for a Brand/Non-Formulary drug by submitting a drug request form with documentation of medical necessity.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

2pharmacy benefit structures

$15/$50/$75example 3‑tier copay

$15/$30/$50/$100/$150example 5‑tier copay

specialty excludedmail order noted

MAstate rule referenced

Policy Summary

PayerHealth-New-England

Policy2026 Pharmacy Benefit Options for HMO Essential 5000 LG

Policy CodePolicy N/A

Change TypeNo material change

Effective DateJan 1, 2026

Next Review DateN/A

Key ActionProviders may request prior authorization for a Brand/Non-Formulary drug by submitting a drug request form with documentation of medical necessity.

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Tiered coverage and medical necessity

Covered when conditions below are met; coverage and member cost share depend on the drug's assigned tier and applicable mail-order rules. Brand drugs with FDA‑approved generic equivalents require demonstration of medical necessity to be covered at brand cost sharing.

ALL of the following

Tier assignment and member cost share
- 3‑tier option: drugs are assigned to Generic/Tier 1, Brand Formulary/Tier 2, or Brand Non‑Formulary/Tier 3 and member copays follow the selected plan schedule (examples include $15/$50/$75 retail; corresponding mail‑order copays shown in plan materials).
- 5‑tier option: drugs are assigned to Tier 1 (Generic), Tier 2 (Brand Formulary), Tier 3 (Brand Non‑Formulary), Tier 4 (Formulary Specialty), or Tier 5 (Non‑Formulary Specialty) and member copays follow the selected plan schedule (examples include $15/$30/$50/$100/$150 retail; corresponding mail‑order copays shown in plan materials).
  Mail order is not available for Specialty drugs.
Generic substitution rule: Generic/Tier 1 drugs are FDA‑approved equivalents to brand products; in Massachusetts pharmacists are required to dispense the generic unless the prescriber writes 'no substitution' on the prescription.
Brand with generic equivalent — medical necessity requirement
- Provider may request prior authorization by completing and faxing a drug request form with documentation of medical necessity for review by Health New England.

ALL of the following

Mail‑order rules: mail‑order copays differ from retail copays as listed in plan options; mail order is not available for Specialty drugs (Tiers 4 and 5 in 5‑tier designs).

Prior Authorization and Provider Requirements

Prior Authorization

Prior authorization required for Brand/Non‑Formulary drugs

Providers may request prior authorization for a Brand/Non-Formulary drug by completing and faxing a drug request form to Health New England and including documentation that demonstrates medical necessity (for example, inadequate response or allergic reaction to generics, or failure of alternatives in the drug class).

Complete the drug request form and fax it to Health New England for review.
Include documentation of medical necessity (e.g., inadequate response or allergic reaction to the generic(s), and failure of alternatives in the drug class).

Tier Definitions

Generic / Tier 1

DefinitionGeneric/Tier 1: Approved by the FDA; contain the same active ingredients as brand-name drugs; are as safe and effective and usually cost less.

State substitution ruleIn Massachusetts, pharmacists are required to dispense generic drugs unless the prescriber writes 'no substitution' on the prescription.

Cost roleLowest copay tier compared with brand/formulary and non-formulary tiers.

Brand Formulary / Tier 2

DefinitionBrand Formulary/Tier 2: Brand drugs marketed under a trademarked name without less expensive generic equivalents and selected for the formulary based on safety, effectiveness, and cost.

Member costCopay higher than generic/Tier 1 but lower than Brand Non-Formulary/Tier 3.

Selection basisIncluded after review of relative safety, effectiveness, and cost among FDA-approved drugs.

Brand Non-Formulary / Tier 3

DefinitionBrand Non-Formulary/Tier 3: Brand name drugs not selected as Brand/Formulary drugs; covered but at the highest copay level (or higher copay in 5-tier design).

Medical necessity & prior authBrand drugs with FDA-approved generics are covered only if Medical Necessity is shown; providers may request prior authorization by submitting a drug request form with documentation (e.g., inadequate response or allergic reaction to generics, failure of alternatives).

Cost handlingCovered at highest copay; Health New England does not waive or reduce copays for Brand/Non-Formulary drugs (5-tier statement).

Formulary Specialty / Tier 4

DefinitionFormulary Specialty/Tier 4: Specialty drugs selected for the formulary based on review of relative safety, effectiveness, and cost among FDA-approved drugs.

Coverage statusThese specialty drugs are included on the formulary (Tier 4) and are covered according to specialty benefit rules.

Selection basisSelected after review of safety, effectiveness, and cost of FDA-approved specialty drugs.

Non-Formulary Specialty / Tier 5

DefinitionNon-Formulary Specialty/Tier 5: Brand specialty drugs not selected as Formulary Specialty drugs; include brand drugs that have formulary generic and brand alternatives.

Member costCovered at the highest copay level for specialty tiers.

Formulary relationTier 5 consists of specialty drugs Health New England did not select for Tier 4 and often have formulary alternatives.

OpenPayer

2026 Pharmacy Benefit Options for HMO Essential 5000 LG

Tiered Coverage and Medical Necessity

Tier Labels and Coding

Prior Authorization and Provider Requirements

Tier Definitions